Wei Hao
5
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
40.0%
2 terminated/withdrawn out of 5 trials
50.0%
-36.5% vs industry average
60%
3 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence
Role: lead
An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence
Role: lead
A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis
Role: lead
A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis
Role: lead
An Study of Aripiprazole in the Treatment of Methamphetamine Dependence
Role: lead
All 5 trials loaded